Medicina
Department
Carlos Manuel
González
Publications by the researcher in collaboration with Carlos Manuel González (27)
2022
-
Development and feasibility of 4 checklists for the evaluation of comorbidity in patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis: GECOAI Project
Reumatologia Clinica, Vol. 18, Núm. 2, pp. 114-123
2021
-
Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study
European Journal of Clinical Nutrition, Vol. 75, Núm. 9, pp. 1368-1382
2020
-
Disease features associated with a low disease impact in patients with psoriatic arthritis: Results of a cross-sectional multicenter study
Arthritis Research and Therapy, Vol. 22, Núm. 1
2019
-
Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis
Annals of the Rheumatic Diseases, Vol. 78, Núm. 3, pp. 355-364
-
Spanish Registry of Recent-onset Psoriatic Arthritis (REAPSER study): Aims and methodology
Reumatologia Clinica, Vol. 15, Núm. 5, pp. 252-257
-
Very low disease activity, DAPSA remission, and impact of disease in a Spanish population with psoriatic arthritis
Journal of Rheumatology, Vol. 46, Núm. 7, pp. 710-715
2018
-
Recommendations for the Management of Comorbidity in Patients With Axial Spondyloarthritis in Clinical Practice
Reumatologia Clinica, Vol. 14, Núm. 6, pp. 346-359
2017
-
Minimal disease activity and impact of disease in psoriatic arthritis: A Spanish cross-sectional multicenter study
Arthritis Research and Therapy, Vol. 19, Núm. 1
2016
-
Urine metabolome profiling of immune-mediated inflammatory diseases
BMC Medicine, Vol. 14, Núm. 1
2015
-
A deletion at adamts9-magi1 locus is associated with psoriatic arthritis risk
Annals of the Rheumatic Diseases, Vol. 74, Núm. 10, pp. 1875-1881
2014
-
PDE3A-SLCO1C1 locus is associated with response to anti-tumor necrosis factor therapy in psoriatic arthritis
Pharmacogenomics, Vol. 15, Núm. 14, pp. 1763-1769
2013
-
Comparación de 2 estrategias de derivación en el diagnóstico de la espondiloartritis axial en España. Estudio RADAR
Reumatologia Clinica, Vol. 9, Núm. 6, pp. 348-352
2011
-
High-dose etanercept in ankylosing spondylitis: Results of a 12-week randomized, double blind, controlled multicentre study (LOADET study)
Rheumatology, Vol. 50, Núm. 10, pp. 1828-1837
-
Prevalence of vertebral fractures by semiautomated morphometry in patients with ankylosing spondylitis
Journal of Rheumatology, Vol. 38, Núm. 5, pp. 893-897
2010
-
Fibromyalgia in patients with ankylosing spondylitis: Prevalence and utility of the measures of activity, function and radiological damage
Clinical and Experimental Rheumatology, Vol. 28, Núm. 6 SUPPL. 63
2007
-
Disease pattern of spondyloarthropathies in Spain: Description of the first national registry (REGISPONSER) - Extended report
Rheumatology, Vol. 46, Núm. 8, pp. 1309-1315
2005
-
Effectiveness of reducing infliximab dose interval in non-responder patients with refractory spondyloarthropathies. An open extension of a multicentre study
Rheumatology, Vol. 44, Núm. 12, pp. 1555-1558
2002
-
Clinical features and predictive factors in psoriatic arthritis-related uveitis
Seminars in Arthritis and Rheumatism, Vol. 31, Núm. 4, pp. 264-270
-
Psoriatic spondyloarthropathy: A comparative study between HLA-B27 positive and HLA-B27 negative disease
Seminars in Arthritis and Rheumatism, Vol. 31, Núm. 6, pp. 413-418
2001
-
Absence of pulmonary fibrosis in patients with psoriatic arthritis treated with weekly low-dose methotrexate
Clinical and Experimental Rheumatology, Vol. 19, Núm. 6, pp. 727-730